Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.2MFederal grants as PI3 awards
0Patents grantedNone matched
165Papers5,012 citations
Federal awards and patents by year
AwardsPatents
3 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 4, 2021 | NIH | SBIR Phase II A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease | $934K | IMMUNOGENICS LLC |
| Sep 6, 2020 | NIH | SBIR Phase II A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease | $978K | IMMUNOGENICS LLC |
| Aug 6, 2019 | NIH | SBIR Phase II A Clinical Study of Latiglutenase as a Treatment for Type 1 Diabetics with Celiac Disease | $293K | IMMUNOGENICS LLC |
1 patents as inventor
- US IMMUNOGENICS LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#900
Awards as PI#822
Patents#273
Companies
- IMMUNOGENICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.